Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MANT
3576
DELISTED
Mantech International Corp
MANT
| $3.21M | ﹤0.01% |
46,924
-49,239
| -51% | -$3.62M |
|
3577
Hackett Group
HCKT
$265M
| $3.21M | ﹤0.01% |
237,062
+84,388
| +55% | +$1.16M |
|
3578
VanEck Long Muni ETF
MLN
$681M
| $3.21M | ﹤0.01% |
151,645
-1,375
| -0.9% | -$28.2K |
|
3579
CALL
Teledyne Technologies
TDY
$31.5B
| $3.2M | ﹤0.01% |
10,300
-500
| -5% | -$164K |
|
|
BRFS
3580
DELISTED
BRF SA
BRFS
| $3.2M | ﹤0.01% |
+806,543
| New | +$3.11M |
|
3581
CALL
Amplify Alternative Harvest ETF
MJ
$110M
| $3.2M | ﹤0.01% |
20,717
-725
| -3% | -$110K |
|
3582
PUT
Cullen/Frost Bankers
CFR
$10.6B
| $3.2M | ﹤0.01% |
42,800
+3,400
| +9% | +$237K |
|
|
ATRI
3583
DELISTED
Atrion Corp
ATRI
| $3.19M | ﹤0.01% |
5,014
-2,154
| -30% | -$1.41M |
|
3584
PUT
AeroVironment
AVAV
$9.76B
| $3.19M | ﹤0.01% |
40,100
+22,500
| +128% | +$1.45M |
|
|
WBT
3585
DELISTED
Welbilt, Inc.
WBT
| $3.19M | ﹤0.01% |
524,293
-478,897
| -48% | -$2.59M |
|
3586
CALL
MSC Industrial Direct
MSM
$6.91B
| $3.19M | ﹤0.01% |
43,800
+22,900
| +110% | +$1.48M |
|
|
CHAQ.U
3587
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| $3.18M | ﹤0.01% |
+303,069
| New | +$3.04M |
|
3588
PUT
Crocs
CROX
$6.32B
| $3.18M | ﹤0.01% |
86,400
+14,500
| +20% | +$384K |
|
3589
Ichor Holdings
ICHR
$2.66B
| $3.18M | ﹤0.01% |
119,649
+56,059
| +88% | +$1.28M |
|
|
AAN.A
3590
CALL
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $3.18M | ﹤0.01% |
70,000
+54,100
| +340% | +$2.46M |
|
|
SEE
3591
DELISTED
Sealed Air
SEE
| $3.18M | ﹤0.01% |
96,657
-1,007,346
| -91% | -$30.2M |
|
|
MDRX
3592
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.17M | ﹤0.01% |
469,008
-261,499
| -36% | -$1.7M |
|
3593
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
| $3.17M | ﹤0.01% |
67,500
+6,300
| +10% | +$286K |
|
3594
CALL
MasTec
MTZ
$23.9B
| $3.17M | ﹤0.01% |
70,700
+36,400
| +106% | +$1.38M |
|
|
SIVB
3595
DELISTED
SVB Financial Group
SIVB
| $3.17M | ﹤0.01% |
14,696
-10,694
| -42% | -$2.06M |
|
3596
CALL
Ascendis Pharma A/S
ASND
$16.3B
| $3.17M | ﹤0.01% |
21,400
+4,700
| +28% | +$645K |
|
3597
Adient
ADNT
$1.57B
| $3.16M | ﹤0.01% |
192,605
+14,339
| +8% | +$218K |
|
3598
State Street SPDR S&P Capital Markets ETF
KCE
$480M
| $3.16M | ﹤0.01% |
56,298
+16,416
| +41% | +$863K |
|
|
SGI
3599
PUT
Somnigroup International
SGI
$13.9B
| $3.16M | ﹤0.01% |
175,600
-173,200
| -50% | -$2.48M |
|
3600
PUT
Nektar Therapeutics
NKTR
$2.49B
| $3.16M | ﹤0.01% |
9,087
-286
| -3% | -$89.2K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.